These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10608733)

  • 21. The therapeutic potential of extracorporeal photopheresis.
    Girardi M
    Clin Adv Hematol Oncol; 2006 May; 4(5):349-50. PubMed ID: 16728944
    [No Abstract]   [Full Text] [Related]  

  • 22. Extracorporeal photopheresis: Lighting the way to immunomodulation.
    Babic AM
    Am J Hematol; 2008 Jul; 83(7):589-91. PubMed ID: 18335565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
    Rao V; Saunes M; Jørstad S; Moen T
    Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal photopheresis: Focus on therapeutic immunomodulation.
    Couriel DR
    Transfus Apher Sci; 2015 Apr; 52(2):149-50. PubMed ID: 25747959
    [No Abstract]   [Full Text] [Related]  

  • 25. [Extracorporeal photopheresis in dermatology].
    Pérez-Carmona L; Harto-Castaño A; Díez-Recio E; Jaén-Olasolo P
    Actas Dermosifiliogr; 2009; 100(6):459-71. PubMed ID: 19709550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
    Zackheim HS
    J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extracorporeal photochemotherapy: review of its mechanisms of action and clinical applications].
    Vanheste S; Vereecken P; Lambermont M; Heenen M; Bron D
    Rev Med Brux; 2007; 28(5):445-51. PubMed ID: 18069519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal photopheresis: a review.
    Oliven A; Shechter Y
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous lymphomas: what can we learn from location?
    Grange F; Antonicelli F
    Arch Dermatol; 2009 Jun; 145(6):710-2. PubMed ID: 19528430
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the treatment of primary cutaneous T-cell lymphoma.
    Rosen ST
    Clin Adv Hematol Oncol; 2007 May; 5(5):347-8. PubMed ID: 17673888
    [No Abstract]   [Full Text] [Related]  

  • 35. [Photopheresis for cutaneous T-cell lymphomas].
    Laroche L
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S37-8. PubMed ID: 16385898
    [No Abstract]   [Full Text] [Related]  

  • 36. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photochemotherapy--present and future.
    Knobler R
    Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
    J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.